Marina W. Delpin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marina W. Delpin has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Alice R. Jones
School of Biological Sciences and Environment Institute, University of Adelaide
1 shared publication - Andrew J. Lowe
Environment Institute, Adelaide University, Adelaide, Australia
1 shared publication - Anna M. Kotarba-Morley
Environment Institute, Adelaide University, Adelaide, Australia
1 shared publication - Antony Eagle
Philosophy, School of Humanities, Adelaide University, Adelaide, Australia
1 shared publication - Ariella Helfgott
Environment Institute, Adelaide University, Adelaide, Australia
1 shared publication - Boyke Bunk
Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstraße 7B, 38124 Braunschweig, Germany
1 shared publication
Latest Publications
- 11 May 2026
- Published by Springer Nature in Nature Sustainability
- Vol. 9 (7) , 1-3
Evaluative governance for climate action in Australia
- 11 May 2026
- Published by Springer Nature in Nature Sustainability
- Vol. 9 (7) , 1-3
Evaluative governance for climate action in Australia
- Open Access
- 16 September 2016
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 7, 1461
Production of the Bioactive Compounds Violacein and Indolmycin Is Conditional in a maeA Mutant of Pseudoalteromonas luteoviolacea S4054 Lacking the Malic Enzyme
It has previously been reported that some strains of the marine bacterium Pseudoalteromonas luteoviolacea produce the purple bioactive pigment violacein as well as the antibiotic compound indolmycin, hitherto only found in Streptomyces. The purpose of the present study was to determine the relative role of each of these two compounds as antibacterial compounds in P. luteoviolacea S4054. Using Tn10 transposon mutagenesis, a mutant strain that was significantly reduced in violacein production in mannose-containing substrates was created. Full genome analyses revealed that the vio-biosynthetic gene cluster was not interrupted by the transposon; instead the insertion was located to the maeA gene encoding the malic enzyme. Supernatant of the mutant strain inhibited Vibrio anguillarum and Staphylococcus aureus in well diffusion assays and in MIC assays at the same level or even more pronounced as the wild type strain. The mutant strain killed V. anguillarum in co-culture experiments as efficiently as the wild type. Using UHPLC-UV/Vis analyses, we quantified violacein and indolmycin, and the mutant strain only produced 7-10% the amount of violacein compared to the wildtype strain. In contrast, the amount of indolmycin produced by the mutant strain was about 300% that of the wildtype. Since inhibition of V. anguillarum and S. aureus by the mutant strain was similar to that of the wild type, it is concluded that violacein is not the major antibacterial compound in P. luteoviolacea. We furthermore propose that production of violacein and indolmycin may be metabolically linked and that yet unidentified antibacterial compound(s) may be play a role in the antibacterial activity of P. luteoviolacea.
- 16 September 2016
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 7, 1461
Open AccessProduction of the Bioactive Compounds Violacein and Indolmycin Is Conditional in a maeA Mutant of Pseudoalteromonas luteoviolacea S4054 Lacking the Malic Enzyme
It has previously been reported that some strains of the marine bacterium Pseudoalteromonas luteoviolacea produce the purple bioactive pigment violacein as well as the antibiotic compound indolmycin, hitherto only found in Streptomyces. The purpose of the present study was to determine the relative role of each of these two compounds as antibacterial compounds in P. luteoviolacea S4054. Using Tn10 transposon mutagenesis, a mutant strain that was significantly reduced in violacein production in mannose-containing substrates was created. Full genome analyses revealed that the vio-biosynthetic gene cluster was not interrupted by the transposon; instead the insertion was located to the maeA gene encoding the malic enzyme. Supernatant of the mutant strain inhibited Vibrio anguillarum and Staphylococcus aureus in well diffusion assays and in MIC assays at the same level or even more pronounced as the wild type strain. The mutant strain killed V. anguillarum in co-culture experiments as efficiently as the wild type. Using UHPLC-UV/Vis analyses, we quantified violacein and indolmycin, and the mutant strain only produced 7-10% the amount of violacein compared to the wildtype strain. In contrast, the amount of indolmycin produced by the mutant strain was about 300% that of the wildtype. Since inhibition of V. anguillarum and S. aureus by the mutant strain was similar to that of the wild type, it is concluded that violacein is not the major antibacterial compound in P. luteoviolacea. We furthermore propose that production of violacein and indolmycin may be metabolically linked and that yet unidentified antibacterial compound(s) may be play a role in the antibacterial activity of P. luteoviolacea.
- 1 February 2016
- Published by Elsevier in Journal of Biotechnology
- Vol. 219, 90-97
Surface modification of an organic hessian substrate leads to shifts in bacterial biofilm community composition and abundance
- 1 February 2016
- Published by Elsevier in Journal of Biotechnology
- Vol. 219, 90-97
Surface modification of an organic hessian substrate leads to shifts in bacterial biofilm community composition and abundance